肌少症共识解读及研究现状

Interpretation of consensus for sarcopenia and research status quo

肌少症对老年人危害大,会导致功能下降、跌倒、骨折、死亡等。至2010年以来,老年人肌少症欧洲工作组(European Working Group on Sarcopenia in Older People,EWGSOP)、美国国立卫生研究院基金会(US Foundation for the National Institutes of Health,FNIH)肌少症项目组、亚洲肌少症工作组(Asia Working Group for Sarcopenia,AWGS)、肌少症国际工作组(International Working Group for Sarcopenia,IWGS)等分别发表了肌少症共识。对各工作组肌少症共识进行解读,对研究现状进行简要总结,以期提高人们对肌少症的认识,为临床筛查、识别、诊断、治疗、干预肌少症提供依据。

Sarcopenia is very harmful to the elderly,which can lead to functional decline,falls,fractures,death,etc.Since 2010,the European Working Group on Sarcopenia in Older People(EWGSOP),the US Foundation for the National Institutes of Health(FNIH)Sarcopenia Project Group,Asian Working Group for Sarcopenia(AWGS),and the International Working Group for Sarcopenia(IWGS)respectively published the consensus for sarcopenia.This article interprets the consensus for sarcopenia of each working group,and briefly summarizes the research status quo,in order to improve people′s understanding of sarcopenia,and provide the evidence for clinical screening,identification,diagnosis,treatment,and intervention of sarcopenia.